Everolimus Tablets for Oral Suspension

Dosage Form


Return Goods Policy

Everolimus Tablets for Oral Suspension

Compare To: AFINITOR DISPERZĀ® Full Prescribing Information
Active Ingredients: Everolimus
 
To report an Adverse Event for this product please call 1-855-204-1431 or email drugsafety@anipharmaceuticals.com.
Adverse Events may also be reported to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Strength: 2 mg
Description: White to slightly yellowish speckled, round flat tablets, no score, debossed with "N 773" on one side and plain on the other side, free from physical defects
Size and NDC: 28s | 70954-773-20
Strength: 3 mg
Description: White to slightly yellowish speckled, round flat tablets, no score, debossed with "N 774" on one side and plain on the other side, free from physical defects
Size and NDC: 28s | 70954-774-20
Strength: 5 mg
Description: White to slightly yellowish speckled, round flat tablets, no score, debossed with "N 775" on one side and plain on the other side, free from physical defects
Size and NDC: 28s | 70954-775-20




All Products Available in the US

To find out more information about one of our quality pharmaceutical products, you can search or look up your product name in the alphabetized list.